Healthcare provider profile · identity verified

Lacey Kessler, MD

Family Practice · BOWDLE, SD · NPI 1508279738

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	439	57
Losartan Potassium	Losartan Potassium	392	60
Atorvastatin Calcium	Atorvastatin Calcium	319	48
Metoprolol Succinate	Metoprolol Succinate	290	49
Amlodipine Besylate	Amlodipine Besylate	273	49
Rosuvastatin Calcium	Rosuvastatin Calcium	258	47
Omeprazole	Omeprazole	231	42
Furosemide	Furosemide	196	30
Lisinopril	Lisinopril	193	29
Eliquis	Apixaban	183	22
Pantoprazole Sodium	Pantoprazole Sodium	159	25
Sertraline Hcl	Sertraline Hcl	159	24
Gabapentin	Gabapentin	141	23
Hydrochlorothiazide	Hydrochlorothiazide	128	22
Duloxetine Hcl	Duloxetine Hcl	123	16
Metoprolol Tartrate	Metoprolol Tartrate	120	16
Simvastatin	Simvastatin	119	22
Potassium Chloride	Potassium Chloride	118	27
Metformin Hcl	Metformin Hcl	114	21
Spironolactone	Spironolactone	100	17
Allopurinol	Allopurinol	92	14
Escitalopram Oxalate	Escitalopram Oxalate	92	15
Prednisone	Prednisone	87	45
Tamsulosin Hcl	Tamsulosin Hcl	87	14
Pravastatin Sodium	Pravastatin Sodium	83	12
Trazodone Hcl	Trazodone Hcl	75	suppressed
Metformin Hcl Er	Metformin Hcl	73	12
Montelukast Sodium	Montelukast Sodium	73	12
Synthroid	Levothyroxine Sodium	70	12
Fenofibrate	Fenofibrate	69	12
Alprazolam	Alprazolam	68	suppressed
Famotidine	Famotidine	65	13
Glipizide Er	Glipizide	65	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	63	suppressed
Alendronate Sodium	Alendronate Sodium	61	11
Donepezil Hcl	Donepezil Hcl	61	suppressed
Finasteride	Finasteride	61	suppressed
Januvia	Sitagliptin Phosphate	60	suppressed
Jardiance	Empagliflozin	53	suppressed
Carvedilol	Carvedilol	51	suppressed
Ezetimibe	Ezetimibe	50	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	suppressed
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Bumetanide	Bumetanide	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	20
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Glipizide	Glipizide	39	suppressed
Atenolol	Atenolol	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Calcitriol	Calcitriol	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Cefdinir	Cefdinir	34	32
Doxycycline Hyclate	Doxycycline Hyclate	32	21
Tresiba Flextouch U-200	Insulin Degludec	32	suppressed
Pregabalin	Pregabalin	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Digoxin	Digoxin	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Azithromycin	Azithromycin	23	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Primidone	Primidone	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Viibryd	Vilazodone Hcl	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Cephalexin	Cephalexin	19	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Nystatin	Nystatin	16	14
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Amoxicillin	Amoxicillin	15	11
Fentanyl	Fentanyl	15	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	suppressed
Baclofen	Baclofen	14	suppressed
Cartia Xt	Diltiazem Hcl	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Nitroglycerin Patch	Nitroglycerin	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Glyburide	Glyburide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Meloxicam	Meloxicam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error